Janel Corp. (JANL)
37.00
0.00 (0.00%)
USD |
OTCM |
Jan 15, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 43.90M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | -7.50% |
| Valuation | |
| PE Ratio | 8.868 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.2151 |
| Price to Book Value | 1.701 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.9008 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 62.30% |
Profile
| Janel Corp. is a holding company, which engages in the provision of integrated logistics and freight forwarding services. It operates through the following business segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides customs brokerage, warehousing, and distribution services and other value-added logistics services. The Life Sciences segment produces and sells monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Manufacturing segment manufactures and distributes mixing equipment, and apparatus for specific applications within various industries. The company was founded by James N. Jannello in 1974 and is headquartered in New York, NY. |
| URL | http://www.janelcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Industrials |
| Industry | Air Freight & Logistics |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ratings
Profile
| Janel Corp. is a holding company, which engages in the provision of integrated logistics and freight forwarding services. It operates through the following business segments: Logistics, Life Sciences, and Manufacturing. The Logistics segment provides customs brokerage, warehousing, and distribution services and other value-added logistics services. The Life Sciences segment produces and sells monoclonal and polyclonal antibodies, diagnostic reagents, and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Manufacturing segment manufactures and distributes mixing equipment, and apparatus for specific applications within various industries. The company was founded by James N. Jannello in 1974 and is headquartered in New York, NY. |
| URL | http://www.janelcorp.com |
| Investor Relations URL | N/A |
| HQ State/Province | New York |
| Sector | Industrials |
| Industry | Air Freight & Logistics |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |